NCT06442735

Brief Summary

Intrapartum ultrasound monitoring is to be compared with conventional labor monitoring to clarify the accuracy of this technology, and then provide a basis for later related research.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
455

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 18, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

June 4, 2024

Completed
Last Updated

June 4, 2024

Status Verified

May 1, 2024

Enrollment Period

2 years

First QC Date

May 18, 2024

Last Update Submit

May 29, 2024

Conditions

Outcome Measures

Primary Outcomes (5)

  • Duration of the first stage of labor

    Medical record about the length of first stage of labor

    Day 1

  • Duration of the second stage of labor

    Medical record about the length of second stage of labor

    Day 1

  • Number of Participants with fever

    physiological parameter about the body temperature when the patient has fever

    Day 3

  • Number of Participants with the soft birth canal laceration I, II,III, IV

    clinical assessment about the soft birth canal laceration after labor, including I(Perineal skin and vaginal entrance mucosa laceration, little bleeding), II(The lacerated injury has reached the fascia and muscle layer of the perineum, involved the mucous membrane of the posterior wall of the vagina, extended to the groove on both sides of the posterior wall of the vagina and tore upward, the anatomical structure is not easy to identify, and there is more bleeding),III(The lacerated wound extends deep into the perineum, the external anal sphincter is broken, and the rectal mucosa is intact), IV(The anus, rectum and vagina are completely penetrated, the rectointestinal cavity is exposed, the histological tissue is seriously damaged)

    Day 1

  • Number of Participants with postpartum hemorrhage

    total postpartum blood loss in 24 hours measured by weighing method

    Day 1

Study Arms (2)

Intrapartum ultrasound

EXPERIMENTAL

IPUS group women were performed pelvic examination at admission and every 2 to 4 hours during the first stage of labor and at least hourly during the second stage by intrapartum ultrasound.

Other: intrapartum ultrasound

Vaginal examination

ACTIVE COMPARATOR

VE group women were performed pelvic examination at admission and every 2 to 4 hours during the first stage of labor and at least hourly during the second stage by vaginal examination.

Other: vaginal examination

Interventions

In IPUS group, the patient's labor was observed by intrapartum ultrasound.

Intrapartum ultrasound

In VE group, the patient's labor was observed by vaginal examination.

Vaginal examination

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • All pregnant women in the delivery room for vaginal trial labor

You may not qualify if:

  • Those who reject ultrasound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Third Affiliated Hospital of Sun Yat-Sen University

Guangzhou, Guangdong, 510630, China

Location

MeSH Terms

Conditions

Dystocia

Condition Hierarchy (Ancestors)

Obstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

May 18, 2024

First Posted

June 4, 2024

Study Start

January 1, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

June 4, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

All data generated or analyzed during this study are available from the Central Contact Person on reasonable request.

Locations